Acelyrin Ownership | Who Owns Acelyrin?
Acelyrin Ownership Summary
Acelyrin is owned by 12.43% institutional investors, 8.82% insiders, and 78.75% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 6.03% of SLRN shares.
SLRN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Acelyrin | 12.43% | 8.82% | 78.75% |
| Sector | Healthcare Stocks | 56.95% | 9.28% | 33.77% |
| Industry | Biotech Stocks | 68.60% | 8.91% | 22.49% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 6.02M | 6.03% | $18.91M |
| General atlantic | 2.70M | 2.70% | $8.46M |
| State street | 1.44M | 1.44% | $4.53M |
| Rtw investments, lp | 978.31K | 0.98% | $3.07M |
| Charles schwab investment management | 614.47K | 0.62% | $1.93M |
| Los angeles capital management | 122.00K | 0.12% | $383.09K |
| Prelude capital management | 88.18K | 0.09% | $276.89K |
| Tudor investment corp et al | 48.30K | 0.05% | $151.66K |
| Intech investment management | 26.59K | 0.03% | $83.48K |
| China universal asset management | 21.27K | 0.02% | $66.80K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| General atlantic | 2.70M | 0.30% | $8.46M |
| Rtw investments, lp | 978.31K | 0.05% | $3.07M |
| Prelude capital management | 88.18K | 0.02% | $276.89K |
| China universal asset management | 21.27K | 0.01% | $66.80K |
| Los angeles capital management | 122.00K | 0.00% | $383.09K |
| Intech investment management | 26.59K | 0.00% | $83.48K |
| Bfsg | 1.90K | 0.00% | $5.97K |
| Tudor investment corp et al | 48.30K | 0.00% | $151.66K |
| Charles schwab investment management | 614.47K | 0.00% | $1.93M |
| Blackrock funding, inc. /de | 6.02M | 0.00% | $18.91M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| State street | 1.44M | 0.00% | 168.18K |
| Prelude capital management | 88.18K | 0.02% | 58.76K |
| Blackrock funding, inc. /de | 6.02M | 0.00% | 38.49K |
| Intech investment management | 26.59K | 0.00% | 11.04K |
| Charles schwab investment management | 614.47K | 0.00% | 4.80K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Acuta capital partners | - | - | -364.00K |
| Woodline partners lp | - | - | -357.09K |
| Point72 asset management | - | - | -250.30K |
| General atlantic | 2.70M | 0.30% | -194.34K |
| Artia global partners lp | - | - | -93.11K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Allworth financial lp | 65.00 | - | 65.00 | $132.00 |
| Skopos labs | 62.00 | 0.00% | 62.00 | $195.00 |
Sold Out
| Holder | Change |
|---|---|
| Capital performance advisors llp | -102.00 |
| Clearstead advisors | -114.00 |
| Srs capital advisors | -185.00 |
| Virtu financial | -10.08K |
| Cubist systematic strategies | -19.25K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 24 | -80.49% | 12,406,379 | -85.49% | 12 | 0.17% | 12 | -81.54% | 7 | -79.41% |
| Sep 30, 2024 | 123 | 7.89% | 85,479,826 | -1.74% | 85 | 1.11% | 65 | -7.14% | 34 | 36.00% |
| Jun 30, 2024 | 114 | -7.32% | 86,992,477 | -4.26% | 87 | 1.02% | 70 | -2.78% | 25 | -13.79% |
| Mar 31, 2024 | 123 | 6.03% | 90,862,849 | 7.15% | 92 | 0.64% | 72 | 9.09% | 29 | 7.41% |
| Dec 31, 2023 | 116 | -3.33% | 84,798,553 | 1.17% | 120 | 1.61% | 66 | -10.81% | 27 | 12.50% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 17, 2024 | Becker Daniel J. | - | Sell | $6.86 |
| Jan 02, 2024 | Lin Shao-Lee | Chief Executive Officer | Sell | $79.19K |
| May 09, 2023 | Westlake BioPartners Fund II, L.P. | - | Buy | $22.50M |
| May 09, 2023 | Svoronos Dawn | - | Buy | $270.00K |
| May 09, 2023 | Gosebruch Henry O | - | Buy | $900.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
| 2024 Q3 | - | 1 |
| 2024 Q1 | - | 1 |
| 2023 Q4 | - | - |
SLRN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools